A Joint Model of Longitudinal CVD Risk Factors, Medication Use, and Time-to-Terminal Events
By: Zeynab Aghabazaz , Michael J Daniels , Donald M Lloyd-Jones and more
Potential Business Impact:
Predicts heart attack risk better with medicine.
We introduce a novel Bayesian approach for jointly modeling longitudinal cardiovascular disease (CVD) risk factor trajectories, medication use, and time-to-events. Our methodology incorporates longitudinal risk factor trajectories into the time-to-event model, considers the temporal aspect of medication use, incorporates uncertainty due to missing medication status and medication switching, and analyzes the impact of medications on CVD events. Our research aims to provide a comprehensive understanding of the effect of CVD progression and medication use on time to death, enhancing predictive accuracy and informing personalized intervention strategies. Using data from a cardiovascular cohort study, we demonstrate the model's ability to capture detailed temporal dynamics and enhance predictive accuracy for CVD events.
Similar Papers
Joint Modeling of Longitudinal and Survival Data: A Bayesian Approach for Predicting Disease Progression
Methodology
Predicts illness spread and patient survival better.
Combining longitudinal cohort studies to examine cardiovascular risk factor trajectories across the adult lifespan
Methodology
Predicts heart problems years before they happen.
Bayesian Semiparametric Joint Dynamic Model for Multitype Recurrent Events and a Terminal Event
Methodology
Helps doctors predict heart attack risks better.